Growth Metrics

Maxlinear (MXL) EBITDA Margin (2016 - 2025)

Maxlinear (MXL) has disclosed EBITDA Margin for 16 consecutive years, with 10.92% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 3376.0% to 10.92% in Q4 2025 year-over-year; TTM through Dec 2025 was 27.13%, a 3482.0% increase, with the full-year FY2025 number at 27.13%, up 3482.0% from a year prior.
  • EBITDA Margin was 10.92% for Q4 2025 at Maxlinear, up from 32.65% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 18.23% in Q1 2022 to a low of 82.3% in Q3 2024.
  • A 5-year average of 15.5% and a median of 7.07% in 2023 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: tumbled -8930bps in 2024, then soared 4965bps in 2025.
  • Maxlinear's EBITDA Margin stood at 11.83% in 2021, then rose by 20bps to 14.16% in 2022, then plummeted by -335bps to 33.3% in 2023, then plummeted by -34bps to 44.67% in 2024, then soared by 76bps to 10.92% in 2025.
  • Per Business Quant, the three most recent readings for MXL's EBITDA Margin are 10.92% (Q4 2025), 32.65% (Q3 2025), and 22.62% (Q2 2025).